Related Experiment Videos
High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer
Acta Oncologica (Stockholm, Sweden)
|June 18, 2010
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer.
International journal of molecular medicine·2026
Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.
Experimental hematology & oncology·2025
IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signalling.
British journal of pharmacology·2025
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer.
International journal of oncology·2025
Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2024
Continuous intrathecal therapy for refractory cancer pain: A systematic review and meta-analysis focusing on partially implanted devices.
Acta oncologica (Stockholm, Sweden)·2026
Co-mutation patterns and survival associations in lung cancer: a comparative analysis of Swedish and global cohorts.
Acta oncologica (Stockholm, Sweden)·2026
Tools for providing information to patients about high-tech medical resources for treatment of cancer.
Acta oncologica (Stockholm, Sweden)·2026
Primary treatment and relative survival by stage and age in vaginal carcinoma: a population-based SweGCG study.
Acta oncologica (Stockholm, Sweden)·2026
Operationalizing fear of cancer recurrence care: a modified Delphi study establishing a consensus-based clinical pathway for Danish cancer survivors.
Acta oncologica (Stockholm, Sweden)·2026
FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland.
Acta oncologica (Stockholm, Sweden)·2026
Diabetes Status and the Association Between a Coronary Artery Disease Polygenic Risk Score and Incident Coronary Artery Disease in an Iranian Prospective Cohort.
Medical journal of the Islamic Republic of Iran·2026
AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation.
Frontiers in pharmacology·2026
FOXM1 Drives Subtype-Specific Dysregulation of Prognostic miRNAs in Breast Cancer Cells.
Journal of clinical practice and research·2026
Evaluation of Preoperative Factors Associated with Early Postoperative Neurological Outcome in the Treatment of Metastatic Spinal Tumors.
Indian journal of orthopaedics·2026